StockData
argenx SE logo

argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$947.52−3.43 (-0.36%)

Close on Nov 17, 2026Market cap –P/E 48.4Yield –

argenx pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

argenx's pe ratio was 50.0× on Nov 11, 2026, against 71.4× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202650.0×−15.8
2025Dec 31, 202565.8×–

More argenx figures

See a number that looks wrong?